LTBR and inflammatory bowel disease: TNFSF14 (LIGHT) is increasingly recognized as a multifaceted regulator in IBD, capable of amplifying inflammation via HVEM on effector T cells, while also facilitating immune tolerance and resolution through LTβR and, in some settings, HVEM on regulatory T cells (Table 1).